Get started
GLAND PHARMA LTDGLAND PHARMA LTDGLAND PHARMA LTD

GLAND PHARMA LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

GLAND trade ideas

Gland Pharma Investment StockEstablished in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major. Vaise company ekdam best hai and acha khaasa discount pe bhi mil rhi h,,isne 13th august ko 4287 ka high banake falling knife ban gya hai and niche he aaye ja rha h. No doubt company is good, management is good, only stock has corrected. my view is to invest for long term in it..this could be next natco pharma, in long term. Right now it is trading at 1395, best price to enter for long term,,, if we found this stock little more down,,do average out. this is definately going to make you wealthy.. Please like and comment and tell me your views on this falling knife..And please don't forget to follow me on tradingview.com Thankyou
NSE:GLANDLong
by TraderRahulPal
GLAND PHARMA, TOUCHED ITS IPO PRICE!!after its recent quarterly results it fell a lot. its a very good stock for the swing trade. i have mentioned its targets and they are good support for those earlier a month ago, i had posted its 5 waves. and this time i have extended it till its IPO PRICE. its a bit sad, that it came down this low. but its good to buy in dip. i am aiming for the targets mentioned. do check he trend line drawn in RSI indicator too. the stock has touched its bottom, and one can do momentum investing till the stock consolidates in the future.
NSE:GLANDLong
by raghavchoudhary2016
Gland Pharma IndiaSun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
BSE:GLAND
by Sunstorminvest
gland pharmaRevenue from operations in H1 FY22 stood at ₹2,234.4 crore as compared to ₹1,715.7 crore in H1 FY21, witnessing a growth of 30.2% YoY on account of launch of new products and growth in existing products. • PBT (profit before tax) in Q2 FY22 was ₹400.7 crore v/s ₹292.6 crore in Q2 FY21, registering a growth of 36.9% YoY, due to operating leverage benefit and higher capacity utilisation. • Cash flow from operations for the 6-month period ended 30th September, 2021, stood at ₹235.5 crore. • Cash conversion cycle increased to 198 days in H1 FY22 as compared to 180 days in H1 FY21 on account of increase in inventory level. • Fixed asset turnover ratio increased to 3.4x in H1 FY22 in comparison to 3x in H1 FY21. FUTURE OUTLOOK • The company is exploring partnerships to accelerate entry into the Biologics CDMO (contract development manufacturing organisation) market, which has been growing at a CAGR of 15% over the last 5 years. • Leveraging strong knowhow in biologics development and manufacturing of its parent, Fosun Pharma group, it plans to build capabilities for biologics CDMO solutions. • It is planning to start manufacturing Sputnik light vaccine from November, 2021, once it gets export clearance
NSE:GLANDLong
by Tradernawab
1